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ABSTRACT 21 
Objectives - Self-testing for STIs such as HIV and syphilis may empower sexual minorities and expand 22 
uptake of STI testing. While much is known about HIV self-testing (HIVST), less is known about syphilis 23 
self-testing, particularly in low-income settings. The objective of this study is to determine context-specific 24 
facilitators and barriers for self-testing and to assess the usability of syphilis self-testing in Zimbabwe among 25 
men who have sex with men (MSM).  26 
Methods - This mixed methods study was conducted in Harare as part of a larger syphilis self-testing trial. 27 
The study included in-depth interviews (phase one) followed by usability testing and a second interview 28 
(phase two). In-depth interviews were conducted with MSM and key informants prior to syphilis self-testing. 29 
 
* Corresponding author: Clarisse Sri-Pathmanathan, clarisse.sri-pathmanathan@kcl.ac.uk 
† Co-first authors  
Key messages: 
- Syphilis self-testing is an empowering, innovative tool that can be used to expand uptake 
of STI testing among sexual minorities in Zimbabwe.  
- Facilitators and barriers for syphilis self-testing are similar to those observed for HIV self-
testing in Zimbabwe and other low- and middle- income countries. 
- Participants reported high self-test usability and found that self-testing provided increased 
privacy, convenience and autonomy in comparison to facility-based testing.      
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The same MSM then used the syphilis self-test, quantitatively assessed its usability and participated in a 30 
second in-depth interview. Phase one data was analysed using a thematic approach, guided by an adapted 31 
Social Ecological Model conceptual framework. Phase two interviews were analysed using Rapid Assessment 32 
Procedure qualitative methodology, and usability was assessed using a pre-established index, adapted from 33 
existing HIVST evaluation scales. 34 
Results – Twenty MSM and 10 key informants were recruited for phase one in-depth interviews and 16 of 35 
these MSM participated in phase two by completing a syphilis self-test kit. Facilitating factors for self-testing 36 
included the potential for increased privacy, convenience, autonomy and avoidance of social and healthcare 37 
provider stigma. Barriers included the fear to test and uncertainty about linkage to care and treatment. Data 38 
from the usability index suggested high usability (89.6% on a 0-100 scale) among the men who received the 39 
self-test. 40 
Conclusions - MSM in Zimbabwe were willing to use syphilis self-test kits and many of the barriers and 41 
facilitators were similar to those observed for HIVST.  Syphilis self-testing may increase syphilis test uptake 42 
among sexual minorities in Zimbabwe and other low- and middle-income countries.   43 
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Introduction  44 
In 2016, WHO estimated 19.9 million cases of syphilis worldwide, with the highest prevalence in the WHO 45 
African region (1). In the same year, the Global Health Sector Strategy on Sexually Transmitted Infections 46 
sets an impact goal to reduce syphilis infections by 90% globally between 2016-2030. As syphilis is often 47 
asymptomatic, testing is essential to effectively interrupting transmission and innovative strategies are needed 48 
to expand syphilis test uptake (2). Syphilis is more common among men who have sex with men (MSM), with 49 
the WHO reporting a median seroprevalence of 6.0% in this group, estimated from 2016-2017 Global AIDS 50 
Monitoring data (3). A 2020 biobehavioural survey in Zimbabwe found that 5.1% of Harare MSM had 51 
positive treponemal and non-treponemal tests (4). In addition, syphilis and HIV share common sexual risk 52 
behaviours and syphilis facilitates HIV transmission, making syphilis co-infection particularly prevalent in 53 
HIV-infected MSM (2)(5). As PrEP becomes increasingly available in LMIC, risk behaviours may also 54 
change and inadvertently facilitate STI transmission (6). As a result, the WHO strongly recommends routine 55 
syphilis screening among MSM (7).  56 
 57 
MSM face unique health care challenges because of lack of funding for MSM health, lack of testing, legal and 58 
cultural barriers, and stigmatisation, particularly in low- and middle-income countries (LMIC) (8). Stigma 59 
associated with same sex relationships may also extend to healthcare facilities and professionals (9). There is 60 
also a considerable gap in evidence to guide MSM health programs in many LMICs (10). As a result, despite 61 
WHO recommendations, MSM are frequently excluded from syphilis testing services in many LMICs (2).  62 
 63 
One way to expand MSM syphilis test uptake is self-testing. Syphilis self-testing is an approach whereby a 64 
person performs a rapid syphilis test themselves and interprets the result in private. Self-testing may overcome 65 
some of the barriers associated with facility-based testing, promoting early diagnosis, interrupting disease 66 
progression, and reducing syphilis transmission (11). 67 
 68 
HIVST is recommended by the WHO to expand test uptake among stigmatised key populations (7). A 69 
qualitative evidence synthesis found that HIVST empowered people and decreased test-associated stigma 70 
(12). Many countries, including Zimbabwe, have policies to support HIVST as an entry point into sexual 71 
health services (13). However, there is less evidence supporting syphilis self-testing, despite the known 72 
importance of qualitative research in implementing novel diagnostic technologies (12). Syphilis self-testing 73 
pilots have shown that it may increase testing frequency by empowering MSM and reducing the impact of 74 
structural barriers, but there is no data from sub-Saharan Africa (14)(15). Additionally, in the context of the 75 
COVID-19 pandemic, self-testing has become an increasingly important pathway to safely sustain testing 76 
when testing facilities are closed or only partially open. 77 
 78 
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This study aims to understand how syphilis self-testing can create opportunities to test for MSM in Zimbabwe. 79 
The purpose of this study was to determine facilitators and barriers for syphilis self-testing and to assess the 80 
usability of syphilis self-testing as reported by Zimbabwean men who have sex with men (MSM).  81 
 82 
Methods  83 
A two-phased mixed methods study was conducted among MSM in Zimbabwe. We focused on Harare 84 
because of the strong network of MSM community-based organisations in the city. The first phase was prior 85 
to syphilis self-testing and the second phase was after syphilis self-testing. The formative data from both 86 
phases informed a trial protocol aiming to compare syphilis self-testing to facility-based testing in MSM in 87 
Zimbabwe (16). 88 
 89 
In phase one, in-depth interviews were conducted amongst MSM and key informants, by trained and 90 
experienced researchers from the Pangaea Zimbabwe Aids Trust (PZAT), between March and April 2020. We 91 
recruited MSM using snowball sampling (17). Participants needed to meet the following inclusion criteria: 16 92 
years or older, living in Harare, ever had anal or oral sex with another man, born biologically male, and able 93 
to provide informed consent. All MSM were referral facilitators, responsible for offering community support 94 
to individuals who are harder-to-reach. Key informants were healthcare professionals and were purposively 95 
sampled to include providers who had experience with HIV and/or syphilis testing. 96 
 97 
Interviews were conducted using a structured guide, lasted approximately 30 minutes and were audio-98 
recorded. The MSM interview guide was developed to explore prior syphilis- and HIV-testing experiences, 99 
facilitating and deterring factors, and self-testing intervention preferences. Socio-demographic data were also 100 
collected. The key informant interview guide included healthcare provider experiences with HIV and syphilis 101 
testing and treatment services, including population served and challenges faced.  102 
 103 
Interviews were translated and transcribed by PZAT researchers. Transcripts were then entered into Dedoose 104 
8.3.17. The Framework Method was used to guide our analysis (18). Two codebooks were developed based 105 
on an adapted Social Ecological Model to systematically analyse the data, following calculation of the 106 
intercoder agreement. Ultimately our conceptual framework included an individual level, a community level 107 
and a policy and environment-level (Figure 1) (19). The framework was used to organise deductive and 108 
inductive themes emerging from the data, and to create separate analytic memos for MSM and key informant 109 
data. The preliminary findings described in these analytic memos were used to refine the pilot trial protocol 110 
(MRCZ/A/ 2533). 111 
 112 
In phase two, the syphilis self-test distributed to MSM consisted of a Standard Q Syphilis Ab treponemal blood-113 
based rapid test (SD Biosensor), adapted for individual use and interpretation. Individual lancets and buffer 114 
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samples were packaged into sealed plastic pouch, together with an individual test device and an infographic, 115 
created to explain step-by-step use and appropriate disposal of the kit. An instructional video was created and 116 
disseminated to facilitate independent use. Tests were distributed by researchers from PZAT to the same MSM 117 
who had completed in-depth interviews in phase one. It emerged that insufficient quantities of buffer were 118 
provided in some test kits, impeding successful self-test completion. This was however resolved through 119 
community-based distribution of additional buffer samples. 120 
 121 
In phase two (August 2020), PZAT researchers interviewed a sample of 16 MSM who successfully completed 122 
a syphilis self-test. These interviews were conducted under COVID-19 social distancing measures, as per 123 
guidance provided by the Zimbabwe Ministry of Health. Only 16 MSM were interviewed in phase two, as four 124 
of the initial cohort of 20 MSM were lost to follow-up. An exit interview guide was developed to qualitatively 125 
assess specific facilitators and barriers for syphilis self-testing. Participants also completed a survey to establish 126 
quantitative usability of the test, adapted from a HIVST usability index used in South Africa (20). Qualitative 127 
data was analysed following the Rapid Assessment Procedures (RAP), a set of methodologies designed for rapid 128 
assessment of health-seeking behaviour (21). A RAP matrix was developed using the exit interview guide and 129 
Social Ecological Model. Data were then organised into the matrix, by paraphrasing, synthesizing and quoting 130 
from participant responses in interview recordings. This allowed us to simultaneously and systematically 131 
identify similarities, differences and trends in responses (22). A table illustrating the template that was used by 132 
researchers to analyse participant responses regarding the syphilis self-testing kits can be found in Appendix 3.  133 
 134 
Ethical clearance was obtained from both Zimbabwe (MRC/A/2533) and London School of Hygiene and 135 
Tropical Medicine (Ref: 17848). In line with MRCZ guidance, participants were each compensated for their 136 
time. Participants provided informed verbal consent before the start of all interviews. Data was anonymised at 137 
the source and participants were given a unique ID. 138 
 139 
Results  140 
Twenty MSM and 10 key informants were recruited for in-depth interviews in phase one. In phase two, the 141 
whole cohort was contacted but four MSM were lost to follow-up due to relocation or communication 142 
difficulties.  Sixteen MSM were therefore invited to conduct the self-test independently and were 143 
subsequently interviewed. In phase one, 18 of 20 MSM had previously used HIVST (Table 1). All of these 144 
MSM had at least secondary-level education and all but three self-identified as MSM. We observed the 145 
following themes in qualitative data: prior STI and HIV testing experiences, both with self-testing and 146 
facility-based services; usability of the syphilis self-test and how it compares to HIV self-testing; MSM-147 
specific facilitators and barriers for self-testing.   148 
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Table 1 - Demographic characteristics of in-depth interview participants and exit interviews following the 149 
syphilis self-test kit trial 150 
 Men who have sex with 
men 
n (%) 
Phase 1 – in-depth interview  
Age 































Self-reported disclosure of sexual identity  
Out to family, friends or doctors 










Phase 2 – syphilis self-testing exit interview  
History of syphilis facility-based testing  8 (50.0) 
Conducted a syphilis self-test 16 (80.0) 
Tested positive for syphilis  2 (12.5) 
Self-reported disclosure of sexual identity  
In person via community-based organisation 





  152 
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Prior HIV and STI testing experiences  153 
In phase one, eighteen MSM had experienced HIV self-testing before using the oral HIV test. Ten participants 154 
stated they used HIVST every three to six months. In addition, thirteen of the 18 HIVST-experienced MSM 155 
had then attended a facility and were empowered to seek facility-based services.  Key informants confirmed 156 
that syphilis testing is usually reserved for pregnant women, and only three had received training on how to 157 
work with MSM, suggesting MSM are largely neglected by STI services. Some providers recommended 158 
syphilis testing should be mandatory for key populations. 159 
 160 
Syphilis self-test usability and comparison with HIVST  161 
Of the 16 participants in phase two, two (12.5%) tested positive for syphilis. Fifteen participants reported the 162 
clarity of explanations provided in the infographic and video were instrumental to successful test completion. 163 
Overall, MSM reported 89.6% usability for the syphilis self-test on a 0-100 scale. This is described in detail in 164 
Table 2. The main challenge with the test kit, reported by 11 of the 16 participants, was the blood draw using 165 
the capillary pipette. Participants nonetheless felt this particular challenge was warranted for the test to 166 
function. One participant had difficulties extracting the buffer because insufficient quantities were provided. 167 
Four participants had to repeat the test, as they did not provide enough blood for the test to show a result.  168 
 169 
Comparing syphilis self-testing to HIVST  170 
Phase two participants felt that the syphilis and HIV self-test kits had many similarities, including the 171 
potential for privacy and convenience. The major challenge cited was that syphilis self-testing uses a blood 172 
sample whilst most HIVST kits use oral samples.  Two MSM reported a preference for HIVST compared to 173 
syphilis self-testing because of this issue. However, fifteen (94%) participants felt that they trusted the syphilis 174 
test result more because it was blood-based. They also preferred the syphilis self-test because of the clarity of 175 
instructions compared to prior HIVST instructional material.  176 
 177 
Self-testing facilitators and barriers  178 
Facilitating and deterring factors for self-testing were categorised into individual, community and structural-179 
level factors (Table 3). Convenience, privacy, and autonomy were the most cited reasons why MSM preferred 180 
self-testing over facility-based testing.  181 
 182 
Self-testing facilitators 183 
The following factors were facilitators for both HIVST and syphilis self-testing: privacy, autonomy and 184 
empowerment, convenience, user-friendliness, high perceived trust in blood-based tests, avoidance of social 185 
and healthcare provider stigma, monetary and time savings, and reduced contact with facility-based services 186 
in the COVID-19 context.  All MSM participants felt comfortable testing alone and stated they would prefer 187 
doing their next test at home, in order to be the first to see their results. In comparison, three participants   188 
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Table 2 - Usability index of the syphilis self-test based on a stepwise questionnaire administered in phase two 189 






Did you find it easy to read/use the 
information sheet? 
16 0 100 
Did you find it easy to watch/use 
the instructional video? 
16 0 100 
Was it difficult for you to remove 
the kit components from the pack? 
1  15  93.8 
Did you verify that the silica gel 
pouch was yellow, to confirm their 
test was valid for use? 
16  0 100 
Did you remove the yellow shield 
from the lancet? 
16 0 100 
Did you have difficulty lancing 
(pricking) their finger using the 
blue lancet? 
1  15  93.8 
Did you have difficulty forming a 
blood droplet? 
5  11  68.8 
Were you able to pick up a blood 
drop up to the black line of the 
capillary pipette? 
5  11  31.2 
Were you able to open the green 
buffer bottle? 
16  0 100 
Were you able to use the pink 
pipette to pick up the buffer? 
15  1 93.8 
Did you drop three drops into the 
test device well? 
15 1 93.8 
Was a control line present on the 
test device? 
12 4 75.0 
Did you trust the self-test result? 15 1 93.8 
Did you quit the process at any 
point? 
0 16 100 
Did you continue the process 
despite a missed or incorrect 
step? 
0 16 100 
Total Usability Index   89.6% 
  190 
 
‡ The usability index (UI) was calculated based on the method used in the HIVST paper from which the index itself was 
extracted.  The original UI is based on WHO literature on Diagnostic Assessment for submission to prequalification. 
Like in the HIVST study, we tracked all successful steps, in order to quantify a usability index, expressed as a percentage 
(20) 
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stated that facility-based testing did not provide adequate levels of privacy. MSM liked that they could 191 
conduct their test without the involvement of a healthcare provider and the convenience of it.  192 
 193 
MSM highlighted that the lengthy waiting periods for in-facility testing are an important deterring factor. A 194 
rapid self-test could contribute to speeding up diagnosis, reducing treatment delay and more efficiently 195 
interrupting syphilis transmission. Seven participants in fact mentioned that HIV self-testing empowered them 196 
to test more frequently and take control of their sexual health. All phase two participants stated that the blood 197 
draw increased their trust in the syphilis self-test. Two MSM noted the blood draw for syphilis facility-based 198 
testing is more painful than the self-test, due to the nature of the self-testing lancets provided, and thus would 199 
opt for the self-test.  Participants explained that they preferred the pressure-activated lancets provided in the 200 
study self-test kits, in comparison to the twist-top universal lancets used in-facility.  201 
 202 
Participants liked that they were able to avoid being identified at a facility and stigmatized by members of 203 
their own community. Additionally, several MSM observed that self-testing prevented hostility from 204 
providers or other society members, therefore decreasing test-associated stigma. Key informants in phase one 205 
explained they valued self-testing because of the potential to reduce contact with clients, especially in the 206 
context of the COVID-19 pandemic.  207 
 208 
Barriers to self-testing 209 
Themes related to barriers included the following: the challenge of self-sampling blood, reluctance to test due 210 
to poor awareness, stigma at community-level following at-home testing, indefinite linkage to care and 211 
treatment availability. Twelve participants experienced difficulty with the blood draw that they attributed to 212 
inexperience. One participant was concerned about the bio-hazard potential with test-kit material disposal. 213 
Some MSM mentioned that self-test uptake is jeopardised among the wider community of MSM by poor 214 
awareness and the perception that they do not have STIs. MSM also expressed concerns over the fact they 215 
could be profiled or stigmatised within their own community following at-home self-testing. Participants 216 
reported that they would seek confirmatory testing if trusted information was provided on where to go and 217 
what to expect in-facility. These are legitimate concerns that align with phase one qualitative data, which 218 
showed that provider discrimination and treatment shortages exist at structural level.  Multiple key informants 219 
also reported frequent unavailability of the facility-based syphilis tests required for confirmatory testing, as 220 
these are reserved for antenatal care.221 
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Discussion  224 
Our study expands on the limited literature on syphilis self-testing, includes qualitative and quantitative data, 225 
and follows MSM prior to and after self-testing. We found that syphilis self-testing was feasible and highly 226 
acceptable among MSM in Zimbabwe. The high usability index (89.6%) suggests that syphilis self-testing 227 
would be acceptable in this subgroup of MSM. Overall, 12.5% of phase two MSM tested positive for syphilis, 228 
a high proportion considering the relatively small number of participants. Participants reported self-testing 229 
was a convenient method that provided increased privacy, autonomy and diminished vulnerability in 230 
comparison to facility-based testing. The testing challenges associated with the amount of test buffer were 231 
transient and were improved by increasing the quantity of buffer provided.  232 
 233 
Study findings are consistent with HIV self-testing data in Zimbabwe, as well as syphilis self-testing data 234 
from China (23) and the Netherlands (15). Our qualitative data suggested that many of the same facilitators 235 
and barriers for syphilis self-testing exist for HIV self-testing. Self-testing is a private and convenient method 236 
that is preferred over facility-base testing, especially for higher risk individuals. This is reflected in the large 237 
body of evidence that exists for HIV self-testing, which is now well established in Zimbabwe (24). We found 238 
that syphilis self-testing was the first ever syphilis test for half of our study participants. This is consistent 239 
with data from China suggesting that syphilis self-testing may increase test uptake among MSM (23). Recent 240 
data from HIVSTAR in Malawi, Zambia and Zimbabwe also show that HIVST also encourages first-time 241 
HIV testing (25). 242 
 243 
Our qualitative data suggest that syphilis self-testing can empower MSM to test when, where, and with whom 244 
they wish.  This is consistent with a global HIVST qualitative literature showing how self-testing gives agency 245 
to those who test (12)(26). Existing research also shows self-testing can improve testing frequency (27,28). 246 
Providing autonomy, control and creating a culture of testing among vulnerable MSM could potentially help 247 
to build trust in the local health system, which is relatively low according to recent evidence (9). 248 
 249 
One barrier to syphilis self-testing was the uncertainty of linking to confirmatory testing and treatment within 250 
health facilities. Key informants noted that Zimbabwe hospitals have variable access to non-treponemal tests 251 
and stock-outs of penicillin occur. While similar concerns existed for HIVST, linkage to care rates have been 252 
excellent (26). Poor linkage to syphilis care would impact the capacity for testing to translate into public 253 
health benefits for syphilis control. Embedding syphilis self-testing within the HIVST systems could be a way 254 
to enhance linkage to care. HIVST has been part of the Zimbabwe National HIV/AIDS Strategic Plan since 255 
2016. The recent large scale HIVSTAR implementation study used community-based distributors, accounting 256 
for over 75% of test kit distribution, through Population Services International branches, achieving 50.3% 257 
community-level coverage (25). A number of studies in China show successful integration of HIV and 258 
syphilis testing services (11).  259 
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 260 
This study has a number of limitations. Firstly, as a mixed methods study, qualitative results should be 261 
interpreted as only an indication of the preferences of the men interviewed. The MSM participants all had at 262 
least secondary-level education, were educated about STIs and able to access community-based services. They 263 
may therefore be early adopters within the MSM population, more likely to take up health innovations due to 264 
heightened awareness and contact with MSM community organisations (29). Most of the interviewees had 265 
tried HIVST, which could have also made them familiar with the self-testing method and thus more likely to 266 
accept syphilis self-testing. The perspectives of this subset of MSM may be different to those of other, 267 
potentially more marginalised MSM in Zimbabwe. For example, subsets of low literacy MSM have had 268 
problems implementing HIVST and this may also be the case for syphilis self-testing (30).  269 
 270 
This study has implications for research and policy. It has revealed that more research is needed on how we 271 
can integrate syphilis self-testing into established networks of HIV self-testing services to facilitate 272 
implementation. Syphilis self-testing cannot effectively contribute to interrupting syphilis transmission if 273 
facility-based confirmatory testing and treatment is not made accessible to MSM. Clinical trials are needed to 274 
assess the effectiveness and risks of syphilis self-testing in practice. From a policy perspective, many of the 275 
existing HIVST policies could be expanded to cover syphilis self-testing. Further policy development will 276 
help national leadership to embrace syphilis self-testing as a tool for expanding syphilis testing. Improving 277 
testing among key populations can reduce the bridging of syphilis into the general population, likely having an 278 
impact on the overall prevalence of syphilis, with the potential of reducing mother-to-child transmission. 279 
 280 
In conclusion, the findings from this study suggest that syphilis self-testing may decrease user perceived test-281 
associated stigma and empower MSM in an area where same sex relations are condemned. As PrEP is 282 
expanded in Zimbabwe and other LMIC settings, leading to a possible shift in sexual risk behaviours, syphilis 283 
prevalence may increase. Innovative tools such as syphilis self-testing are needed to expand syphilis test 284 
uptake, especially for marginalised populations of MSM.   285 
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Figure 1: An adapted social-ecological framework of factors influencing test uptake and acceptability of a syphilis 402 
self-testing intervention among MSM (19)403 
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